Considering treatment with Venclexta (or its myriad names) or Ibrurinib (and its myriad names) or ACP196/acalabrutinib (and I'm sure it will soon gain another name)? Then make certain that you first read this guest blog:
Incidentally, I'd suggest that the word 'except' was not intended in the first sentence of the section: 'Should I run off to the nearest major cancer center to be treated with this new agent?
If you do not have the 17-p deletion mutation, then at this time you could only receive this drug, except as part of a clinical trial.'
Neil
Written by
AussieNeil
Partner
To view profiles and participate in discussions please or .
It is early in the testing of Venetoclax. However, various researchers are talking about a cure by combining with a ACP-196 or Ibrutinib. This means that you go off all medicine. At the same time inexperienced doctors will kill patients as highlighted in the article due to tumor lysis.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.